ImmunityBio (IBRX) is currently exhibiting significant bearish activity, appearing on the FINRA Reg-SHO threshold list. Data indicates the stock has maintained a short volume ratio exceeding 50% for at least five consecutive trading days. With a short interest of 30.5% of float and a borrow fee of 0.6%, the stock is seeing heavy institutional selling pressure. This sustained failure-to-deliver environment suggests that short sellers are aggressively maintaining positions, creating a potential setup for volatility if covering pressure emerges.
Signal data sourced from Tapeboard. This post is an original analysis prepared by The Forensic Ledger from publicly available data. Not investment advice.
Not investment advice. This is original reporting and analysis prepared by The Forensic Ledger from publicly available data. Nothing here is a recommendation to buy, sell, or hold any security. Always consult the original source and a licensed professional. See our full disclaimer and source-citation policy.